Literature DB >> 16874096

Protective roles for induction of autophagy in multiple proteinopathies.

Fiona M Menzies1, Brinda Ravikumar, David C Rubinsztein.   

Abstract

Many late-onset neurodegenerative diseases, including Parkinson's disease, tauopathies, Huntington's disease and forms of spinocerebellar ataxia, are caused by aggregate-prone proteins. Previously we showed that mutant huntingtin is an autophagy substrate and that autophagy induction reduced soluble and aggregated huntingtin levels and attenuated its toxicity in cell, fly and mouse models of disease. We have recently shown in cell and fly models that autophagy induction may have general protective effects across a range of diseases caused by aggregate-prone intracellular proteins. First, we showed that this strategy reduces the levels of the primary toxin, the aggregate-prone mutant protein. Second, our recent work suggests that autophagy induction may have additional cytoprotective effects by protecting cells against a range of subsequent pro-apoptotic insults.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16874096     DOI: 10.4161/auto.2696

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  15 in total

1.  Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.

Authors:  Amanda M Gleixner; Jessica M Posimo; Deepti B Pant; Matthew P Henderson; Rehana K Leak
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

Review 2.  Protein misfolding, aggregation, and autophagy after brain ischemia.

Authors:  Tianfei Luo; Yujung Park; Xin Sun; Chunli Liu; Bingren Hu
Journal:  Transl Stroke Res       Date:  2013-11-09       Impact factor: 6.829

Review 3.  Protein quality control and degradation in cardiomyocytes.

Authors:  Xuejun Wang; Huabo Su; Mark J Ranek
Journal:  J Mol Cell Cardiol       Date:  2008-05-20       Impact factor: 5.000

4.  Autophagy dysregulation in cell culture and animals models of spinal muscular atrophy.

Authors:  Sara K Custer; Elliot J Androphy
Journal:  Mol Cell Neurosci       Date:  2014-06-28       Impact factor: 4.314

5.  Lithium chloride therapy fails to improve motor function in a transgenic mouse model of Machado-Joseph disease.

Authors:  Sara Duarte-Silva; Andreia Neves-Carvalho; Carina Soares-Cunha; Andreia Teixeira-Castro; Pedro Oliveira; Anabela Silva-Fernandes; Patrícia Maciel
Journal:  Cerebellum       Date:  2014-12       Impact factor: 3.847

Review 6.  Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease.

Authors:  P Hemachandra Reddy; Ulziibat P Shirendeb
Journal:  Biochim Biophys Acta       Date:  2011-11-04

7.  Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease.

Authors:  Patricia Spilman; Natalia Podlutskaya; Matthew J Hart; Jayanta Debnath; Olivia Gorostiza; Dale Bredesen; Arlan Richardson; Randy Strong; Veronica Galvan
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

8.  Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease.

Authors:  Lonnie Schneider; Jianhua Zhang
Journal:  Mol Neurodegener       Date:  2010-04-13       Impact factor: 14.195

9.  Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies.

Authors:  Lynn Bedford; David Hay; Anny Devoy; Simon Paine; Des G Powe; Rashmi Seth; Trevor Gray; Ian Topham; Kevin Fone; Nooshin Rezvani; Maureen Mee; Tim Soane; Robert Layfield; Paul W Sheppard; Ted Ebendal; Dmitry Usoskin; James Lowe; R John Mayer
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

10.  Neocortex and allocortex respond differentially to cellular stress in vitro and aging in vivo.

Authors:  Jessica M Posimo; Amanda M Titler; Hailey J H Choi; Ajay S Unnithan; Rehana K Leak
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.